Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cal Cohen

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
AIDS Treatment News|February 19, 2005
Weekend treatment interruptions for certain well-controlled patients: interview with Cal Cohen, M.D. Interview by John S. JamesCal Cohen
AIDS Treatment News|December 15, 2004
New fixed-dose once-a-day starting regimens: interview with Cal Cohen, M.D. Interview by John S. JamesCal Cohen
Research Initiative, Treatment Action : RITA|October 8, 2005
HAART at 10: an interview with Cal CohenCal Cohen
Positively Aware : the Monthly Journal of the Test Positive Aware Network|June 8, 2010
Stalemate--but not checkmate. An expert takes on the challenges. Interview by Jeff BerryCal Cohen
AIDS Treatment News|April 26, 2003
Retroviruses Conference clinical news; interview with Cal Cohen, M.D. Interview by John S. JamesCal Cohen
AIDS Treatment News|May 13, 2003
Treatment interruption; advanced HIV; new ideas: Dr. Cal Cohen interview on retrovirus conference (part 2 or 2). Interview by John S. JamesCal Cohen
IAPAC Monthly|March 5, 2005
New fixed dose once-a-day combinations. Interview by John S. JamesCal Cohen
HIV Clinical Trials|August 28, 2007
Durable suppression possible with FOTO treatment schedule in subjects on nevirapine-based regimensCal Cohen, Amy Colson
Current Opinion in HIV and AIDS|April 18, 2009
Issues in the design of trials comparing management strategies for heavily pretreated patientsAndrew N Phillips, Cal Cohen, Jens D Lundgren
Lancet (London, England)|September 24, 2004
Codevelopment of new antiretrovirals in very treatment-experienced HIV-infected individualsMike Youle, Cal Cohen, Christine Katlama, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
AIDS Treatment News|February 19, 2005
Weekend treatment interruptions for certain well-controlled patients: interview with Cal Cohen, M.D. Interview by John S. JamesCal Cohen
AIDS Treatment News|December 15, 2004
New fixed-dose once-a-day starting regimens: interview with Cal Cohen, M.D. Interview by John S. JamesCal Cohen
Research Initiative, Treatment Action : RITA|October 8, 2005
HAART at 10: an interview with Cal CohenCal Cohen
Positively Aware : the Monthly Journal of the Test Positive Aware Network|June 8, 2010
Stalemate--but not checkmate. An expert takes on the challenges. Interview by Jeff BerryCal Cohen
AIDS Treatment News|April 26, 2003
Retroviruses Conference clinical news; interview with Cal Cohen, M.D. Interview by John S. JamesCal Cohen
AIDS Treatment News|May 13, 2003
Treatment interruption; advanced HIV; new ideas: Dr. Cal Cohen interview on retrovirus conference (part 2 or 2). Interview by John S. JamesCal Cohen
IAPAC Monthly|March 5, 2005
New fixed dose once-a-day combinations. Interview by John S. JamesCal Cohen
HIV Clinical Trials|August 28, 2007
Durable suppression possible with FOTO treatment schedule in subjects on nevirapine-based regimensCal Cohen, Amy Colson
Current Opinion in HIV and AIDS|April 18, 2009
Issues in the design of trials comparing management strategies for heavily pretreated patientsAndrew N Phillips, Cal Cohen, Jens D Lundgren
Lancet (London, England)|September 24, 2004
Codevelopment of new antiretrovirals in very treatment-experienced HIV-infected individualsMike Youle, Cal Cohen, Christine Katlama, et al.
Pageof 3